Taevas
SwitzerlandPharmaceuticals
Product Registration
Market Access for Product-Registration in Switzerland
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to optimize your product's journey from approval to patient access, ensuring sustainable mark
Market
Global
Industry
Product-Registration
Regulator
Diverse National Regulatory & HTA Agencies
Timeline
8-12 weeks for strategy development
Deliverables
Market Access Strategy, HTA/P&R Dossier, Regulatory Roadmap
What We Deliver
6 Pillars of Global Market Access for Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence
We provide in-depth analysis of regulatory frameworks and approval pathways across key global markets, identifying critical requirements and potential challenges.
Country-specific regulatory landscape analysis
Anticipating policy changes and their impact
How It Works
Our Global Market Access Strategy Process
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin with a comprehensive assessment of your product, target markets, and the global regulatory and payer landscape to define strategic imperatives.
Market Snapshot
Market Overview: Global Product Registration & Market Access Landscape
Increasing Payer Scrutiny
Global payers are demanding higher levels of evidence for both clinical effectiveness and economic value, making robust HTA dossiers critical for market access.
Fragmented Regulatory Landscape
Navigating the diverse and often conflicting regulatory requirements across different countries necessitates a strategic, region-specific approach to product registration.
Importance of Early Engagement
Proactive engagement with regulatory authorities, HTA bodies, and key opinion leaders early in development is crucial to streamline the market access pathway.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy
A detailed roadmap outlining optimal pathways for product registration, HTA, and pricing across target global markets.
HTA & Pricing & Reimbursement (P&R) Dossiers
Professionally developed and localized dossiers that articulate your product's value to HTA bodies and payers.
Regulatory & Payer Engagement Plan
A strategic blueprint for interacting with key stakeholders to facilitate positive market access outcomes.
Who This Is For
Use Cases
Biotech Startup
First Global Launch for Novel Therapeutic
A biotech startup with a groundbreaking oncology therapeutic needed to navigate complex regulatory and market access pathways simultaneously across North America, Europe, and Asia. Taevas Life Sciences developed a harmonized global strategy.
Outcome
Achieved successful registration and reimbursement in three major markets within 18 months, securing initial patient access and revenue streams.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Unlock the full potential of your life sciences innovation with a strategic global market access partner. Taevas Life Sciences ensures your product reaches patients efficiently and effectively worldwide.
Navigate global complexities with confidence
Maximize product value and market penetration
Accelerate patient access and commercial success
Benefit from expert insights and global network